A Pharmacogenetic Pilot Study Reveals MTHFR, DRD3, and MDR1 Polymorphisms as Biomarker Candidates for Slow Atorvastatin Metabolizers

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2062-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pilot Study of Blood Biomarker Candidates for Detection of Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2010English

Breath Pentane as a Potential Biomarker for Survival in Hepatic Ischemia and Reperfusion Injury—A Pilot Study

PLoS ONE
Multidisciplinary
2012English

DRD1 Associations With Smoking Abstinence Across Slow and Normal Nicotine Metabolizers

Pharmacogenetics and Genomics
Molecular MedicineGeneticsMolecular Biology
2012English

Membrane-Bound Exosomal HSP70 as a Biomarker for Detection and Monitoring of Malignant Solid Tumours: A Pilot Study

Pilot and Feasibility Studies
Medicine
2020English

Microarray Screening for Novel Preeclampsia Biomarker Candidates

Fetal Diagnosis and Therapy
Nuclear MedicineRadiologyChild HealthGynecologyPerinatologyImagingObstetricsMedicinePediatricsEmbryology
2012English

Pharmacogenetic Approaches to Enhancing Efficacy and Safety of Statins as Illustrated by the Example of Atorvastatin

Safety and Risk of Pharmacotherapy
2020English

Phosphorylated Alpha-Synuclein in Red Blood Cells as a Potential Diagnostic Biomarker for Multiple System Atrophy: A Pilot Study

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2020English

MTHFR C677T and A1298C Polymorphisms and Risk of Lung Cancer: A Comprehensive Evaluation

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2016English

Biomarker Profiles in Women With PCOS and PCOS Offspring; A Pilot Study

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy